ImmunoCellular Therapeutics, Ltd Provides Update on Progress of Key Programs, Including 2008 Financial Results

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced a company update on IMUC’s key product candidates in its platform.

MORE ON THIS TOPIC